These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9929161)

  • 1. bcl-2 protein expression in endometrial carcinoma: the lack of correlation with p53.
    Miturski R; Semczuk A; Tomaszewski J; Jakowicki J
    Cancer Lett; 1998 Nov; 133(1):63-9. PubMed ID: 9929161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
    Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
    Ioffe OB; Papadimitriou JC; Drachenberg CB
    Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 and P53 expression in endometrial carcinoma.
    Erkanli S; Eren F; Pekin S; Bagis T
    J Exp Clin Cancer Res; 2004 Mar; 23(1):97-103. PubMed ID: 15149157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
    Ozkara SK; Corakci A
    Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bax, Bcl-2, and p53 expression in endometrial cancer.
    Sakuragi N; Salah-eldin AE; Watari H; Itoh T; Inoue S; Moriuchi T; Fujimoto S
    Gynecol Oncol; 2002 Sep; 86(3):288-96. PubMed ID: 12217750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study.
    Mirakhor Samani S; Ezazi Bojnordi T; Zarghampour M; Merat S; Fouladi DF
    J Obstet Gynaecol; 2018 Oct; 38(7):999-1004. PubMed ID: 29560769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
    Zheng W; Cao P; Zheng M; Kramer EE; Godwin TA
    Gynecol Oncol; 1996 May; 61(2):167-74. PubMed ID: 8626128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome.
    Peiró G; Diebold J; Baretton GB; Kimmig R; Löhrs U
    Int J Gynecol Pathol; 2001 Oct; 20(4):359-67. PubMed ID: 11603220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
    Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
    Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.
    Erdem O; Erdem M; Dursun A; Akyol G; Erdem A
    Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
    Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
    Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of immunohistochemical staining for p53 expression in hyperplastic endometrium and adenocarcinoma.
    Terlikowski S; Lenczewski A; Famulski W; Sulkowska M; Dobrzycka B; Stasiuk-Barmuta A; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():195-6. PubMed ID: 11820604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the PCNA and P53 proteins expression in the proliferative, hyperplastic and neoplastic human endometrium].
    Zawiślak W; Semczuk A; Miturski R
    Ginekol Pol; 2001 Dec; 72(12A):1549-54. PubMed ID: 11883313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity.
    Yamauchi N; Sakamoto A; Uozaki H; Iihara K; Machinami R
    Int J Gynecol Pathol; 1996 Jul; 15(3):202-8. PubMed ID: 8811380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium.
    Cinel L; Polat A; Aydin O; Düşmez D; Eğilmez R
    Pathol Int; 2002; 52(5-6):384-9. PubMed ID: 12100521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of CD44v6, bcl-2, and vascular endothelial growth factor(VEGF) in endometrial adenocarcinoma].
    Xiang DJ; Xue WQ; Feng YZ; Lu YN; Chen PQ; Wang JY
    Ai Zheng; 2003 Jun; 22(6):592-6. PubMed ID: 12948407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis.
    Riethdorf L; Begemann C; Riethdorf S; Milde-Langosch K; Löning T
    Virchows Arch; 1996 Apr; 428(1):47-51. PubMed ID: 8646368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.